Bosanac, Milana; Amidžić, Jelena; Stefanovic, Maja; Radic, Jelena; Kolarov-Bjelobrk, Ivana; Janicic, Stefan; Gojkovic, Zdenka; Lazić, Bojana; Đokanović, Dejan; Mišan, Aleksandra; Cvetković, Biljana; Stupar, Alena; Martic, Nikola; Andrejic-Visnjic, Bojana
(Sociedad Chilena de Anatomia, 2023-02)
Doxorubicin (DOX) is one of the drugs necessary for the treatment of the 10 most common types of cancer. The leading adverse effect limiting clinical use of DOX is cardiotoxicity. Given that literature data indicate a ...